Apuntes
Jaundice

Contenido del apunte (4)
Página 1
What is Jaundice?
Yellow discolouration of the sclera and skin due to hyperbilirubinaemia (> 50 umol/L)
What is the pathophysiology?
Jaundice is the breakdown product from the catabolism of haem = Made when RBCs are destroyed.
Normally, bilirubin conjugates in the liver making it water soluble so it can be excreted in bile and further broken down to urobilinogen and then stercobilin (colours the stool brown).
When this pathway is disrupted, Jaundice occurs

There are 3 different types:
1. Pre-hepatic
Excessive RBC breakdown overwhelms the liver's ability to conjugate bilirubin
Unconjugated hyperbilirubinaemia
Causes include
Haemolytic anaemia
Gilbert's syndrome
Mild liver disorder affecting bilirubin metabolism due to faulty enzyme
Crigler-Najjar Syndrome
Rare inherited disorder affecting bilirubin metabolism causing non-haemolytic jaundice and brain damage (kernicterus) in infants
2. Intrahepatic / Hepatocellular
Hepatic cell dysfunction means liver loses ability to conjugate bilirubin
Cirrhosis leads to compression of intrahepatic portions of biliary tree to cause obstruction.
Unconjugated / conjugated (mixed) hyperbilirubinaemia
Causes include
Alcoholic liver disease
Viral hepatitis
Iatrogenic (e.g. medication)
Hereditary haemochromatosis
Autoimmune hepatitis
Primary biliary cirrhosis / Primary sclerosing cholangitis
Hepatocellular carcinoma
3. Post-hepatic
Obstruction of biliary drainage
Conjugated hyperbilirubinaemia
Causes included
Intra-luminal (e.g. gallstones)
Mural causes
Cholangiocarcinoma
Strictures
Drug-induced cholestasis
Extra-mural
Pancreatic cancer
Abdominal masses (e.g. lymphomas)
Página 2
Bilirubinuria
Conjugated bilirubin is water soluble so excreted in urine and gives it it's colour.
In conjugated / mixed hyperbilirubinaemias there is dark (coca-cola) urine
Pale stool due to reduced stercobilin
Unconjugated bilirubin isn't water soluble so isn't excreted in urine.
Normal urine seen
Página 3
Investigations
Blood tests
LFT's
Bilirubin = Quantifies degree of jaundice
Albumin = Marker of liver synthesising function
Reduced in liver failure
AST & ALT = Markers of hepatocellular injury (intrahepatic)
AST:ALT > 2 = Alcoholic liver disease likely
AST:ALT around 1 = Viral hepatitis more likely
ALP = Raised in biliary obstruction (post-hepatic problems)
Also raised in pregnancy , bone disease & certain malignancies
Gamma-GT
More specific for biliary obstruction than ALP.
Coagulation studies
Prothrombin can be used as marker for liver synthesis function
FBC
Anaemia + Raised MCV = Megaloblastic anaemia
Thrombocytopenia
U&E's
Specialist blood tests (e.g. Viral serology & Non-infective markers)
Imaging
USS Abdo (1st line)
To identify obstructive pathology or gross liver pathology
MRCP
2nd line when USS Abdo was inconclusive / limited
Also used as work up to surgical intervention
Liver biopsy
When diagnosis not yet made
Liver Screen
Can be done when there is not initial cause for liver dysfunction.
Acute liver injury
Viral serology
Hep A, B, C, D, E
CMV & EBV
Non-infective markers
Paracetamol levels
Caeruloplasmin
ANA & IgG subtypes
Chronic liver injury
Viral serology
Hep B & C
Non-infective markers
Caeruloplasmin
Ferritin & Transferrin saturation
Tissue Transglutaminase antibody
Alpha-1 antitrypsin
Autoantibodies
Página 4
Management
Treat the underlying cause
Obstructive causes may require:
Endoscopic Retrograde Cholangiopancreatography (ERCP)
To remove blockage or stent the common bile duct.
Cholestyramine
Increases biliary drainage
Relieves itching
Anti-histamines
Relieve itching
Monitor for coagulopathy
Treat promptly if any evidence of bleeding or rapid coagulopathy
Vitamin K or Fresh frozen plasma (FFP)
Treat hypoglycaemia orally if possible
If not 5% dextrose is needed
Monitor for hepatic encephalopathy
Confusion due to decompensating chronic liver disease
Treat with laxatives (lactulose/senna) +/- neomycin or rifaximin
Reduces no. of ammonia producing bacteria in bowel
Información
- Descripción
- (HPB) Surgery Apunte sobre Jaundice, creado por Aleda Mackenzie-Reid el 16/03/2020.
- Creado por
- Aleda Mackenzie-Reid
- Visitas
- 0
- Valoración